| Members |
targetComponentId |
| Radial forearm flap |
Radial artery flap (substance) |
| Radiation therapy |
Radiation oncology AND/OR radiotherapy |
| séance ou service de radiothérapie |
Radiation oncology AND/OR radiotherapy |
| Radical neurolysis |
Destruction - action |
| Radiculitis |
Radiculitis |
| Radiochemotherapy NOS |
Combined chemotherapy and radiation therapy (procedure) |
| Radiochemotherapy NOS |
Combined chemotherapy and radiation therapy (procedure) |
| Radiofrequency controlled thermal destruction of lesion of organ NOC |
Destructive procedure |
| Radiofrequency controlled thermal destruction of organ NOC |
Destructive procedure |
| Radiography of ribs |
Radiographic imaging of bone structure of rib (procedure) |
| examen radiologique des côtes, du sternum et de la clavicule |
Radiographic imaging of bone structure of rib, clavicle and sternum |
| Radionuclide dacryocystography |
Radionuclide lacrimal flow study |
| Radioprotective drug |
Administration of radioprotective agent (procedure) |
| Radioprotective drug |
Administration of radioprotective agent (procedure) |
| radiothérapie selon la localisation corporelle |
Radiation oncology AND/OR radiotherapy |
| planification d'une radiothérapie avec imagerie par résonance magnétique |
Magnetic resonance imaging for radiotherapy planning |
| Radiotherapy purpose - NOS |
Radiation oncology AND/OR radiotherapy |
| Radiotherapy purpose - NOS |
Radiation oncology AND/OR radiotherapy |
| Railroading |
Action |
| Ralstonia |
Ralstonia |
| Ralstonia eutropha |
Wautersia eutropha (organism) |
| Ramadier operation |
Drainage of petrous apex of mastoid |
| Ramifying pericementitis fibrosa syndrome |
Periodontal disease |
| Ramipril allergy |
Non-allergic hypersensitivity to ramipril |
| Ramucirumab 10mg/mL conventional release solution for injection |
Product containing only ramucirumab (medicinal product) |
| Ramucirumab 10mg/mL solution for intravenous infusion |
Product containing only ramucirumab (medicinal product) |
| Rancho scale - levels of cognitive functioning |
Rancho Los Amigos Levels of Cognitive Functioning Scale (assessment scale) |
| Range of motion exercise |
Range of motion exercise |
| Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial |
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Rape trauma syndrome |
Post-trauma response |
| Rape trauma syndrome: compound reaction |
Post-trauma response |
| Rape trauma syndrome: silent reaction |
Post-trauma response |
| Rapidly progressive periodontitis |
Aggressive periodontitis |
| Rasburicase 1.5mg powder and solvent for infusion vial |
Rasburicase 1.5 mg powder for solution for infusion vial |
| Rasburicase 7.5mg infusion (pdr for recon) |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Rasburicase 7.5mg infusion (pdr for recon)+solvent |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Raynaud's phenomenon due to drug and/or poison |
Drug-induced Raynaud's phenomenon (disorder) |
| Re-exploration of organ NOC |
Reexploration procedure |
| Re-exploration of organ NOC NOS |
Reexploration procedure |
| Re-exploration of organ NOC OS |
Reexploration procedure |
| Reaction - skin/topical agent |
Adverse reaction to drug |
| Reaction - skin/topical agent |
Adverse reaction to drug |
| Reactive cellular changes associated with intrauterine contraceptive device |
Reactive cellular changes caused by intrauterine contraceptive device (finding) |
| Readmission for retained products of conception, illegal abortion |
Retained products of conception following induced termination of pregnancy |
| Readmission for retained products of conception, legal abortion |
Retained products of conception following induced termination of pregnancy |
| Readmission for retained products of conception, spontaneous abortion |
Retained products after miscarriage (disorder) |
| Ready for enhanced community coping |
Ready for enhanced community coping |
| concept inactivé pour motif non spécifié |
Outdated component (foundation metadata concept) |
| Reattachment of retina by photocoagulation |
Repair of retina for retinal detachment by photocoagulation |
| Recent |
Recent |
| Recessive congenital ichthyosiform erythroderma |
Trichothiodystrophy (disorder) |
| Recomb human follicle stim horm alpha 1200iu inj pdr+diluent |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
| Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
| Recombinant alpha glucosidase 50mg powder for injection solution vial |
Product containing only alpha-glucosidase (medicinal product) |
| Recombinant antihemophilic factor agent 1000 iu injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 1000iu powder for injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 1500 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 1500iu powder for injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 2000 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 2000iu powder for injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 250 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 250iu powder for injection solution vial |
Octocog alfa 250 international unit powder for solution for injection vial |
| Recombinant antihemophilic factor agent 3000 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 500 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 500iu powder for injection solution vial |
Product containing precisely octocog alfa 500 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
| facteur IX de coagulation recombinant 1 000 U.I., fiole de poudre et solvant pour solution pour injection |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 1000iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 1000iu powder for injection solution vial |
Nonacog alfa 1000 international unit powder for solution for injection vial |
| facteur IX de coagulation recombinant 250 U.I., fiole de poudre et solvant pour solution pour injection |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 250iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 250iu powder for injection solution vial |
Nonacog alfa 250 international unit powder for solution for injection vial |
| facteur IX de coagulation recombinant 500 U.I., fiole de poudre et solvant pour solution pour injection |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 500iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 500iu powder for injection solution vial |
Nonacog alfa 500 international unit powder for solution for injection vial |
| facteur VIIa de coagulation recombinant 120 000 U.I., fiole de poudre et solvant pour solution injectable |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 120,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
| facteur VIIa de coagulation recombinant 240 000 U.I., fiole de poudre et solvant pour solution injectable |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 240,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
| facteur VIIa de coagulation recombinant 60 000 U.I., fiole de poudre et solvant pour solution pour injection |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 60,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant human follicle stimulating hormone alfa 150iu/lutropin alfa 75iu powder and solvent for injection solution vial |
Product containing only follitropin alfa and lutropin alfa (medicinal product) |
| Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon) |
Product containing only follitropin alfa (medicinal product) |
| Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent |
Product containing only follitropin alfa (medicinal product) |
| Recombinant human follicle stimulating hormone alpha 150iu powder and solvent for injection solution ampule |
Follitropin alfa 300 unit/mL solution for injection |
| Recombinant human follicle stimulating hormone alpha 37.5iu powder for conventional release solution for injection ampule |
Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon) |
Product containing only follitropin alfa (medicinal product) |
| Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon)+diluent |
Product containing only follitropin alfa (medicinal product) |
| Recombinant human follicle stimulating hormone alpha 75iu powder and solvent for injection solution ampule |
Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Recombinant parathyroid hormone 100micrograms powder for injection solution cartridge and solvent |
Recombinant parathyroid hormone only product |
| Recombinant thrombin 20000iu powder for conventional release cutaneous solution |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
| Recombinant thrombin 20000iu powder for topical solution + 20mL prefilled syringe diluent |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
| Recombinant thrombin 5000iu powder for conventional release cutaneous solution |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
| Recombinant thrombin 5000iu powder for topical solution + 5mL prefilled syringe diluent |
Product containing only thrombin in cutaneous dose form (medicinal product form) |
| Reconstruction of breast using distant flap of skin NEC |
Reconstruction of breast using distant skin flap |
| Reconstruction of jaw using pedicled bone flap |
Reconstruction of mandible using bone flap (procedure) |
| Reconstruction of organ NOC |
Reconstruction procedure |
| Reconstruction of urinary bladder |
Urinary bladder reconstruction |
| Reconstruction using forehead flap graft |
Reconstruction using flap from forehead (procedure) |
| Recreational therapy |
Recreational therapy |
| Rectal prednisolone preparations allergy |
Allergy to prednisolone |
| Rectus muscle sprain |
Strain of rectus abdominus muscle (disorder) |
FHIR